Search

everythinglearnresearchcommunity

for

Search:↓

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Low dose finasteride causes only small changes in PSA levels in older men with BPH.

Shorter PSADT after prostate surgery is linked to higher risk of death.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

The bark of Myrica rubra contains compounds that can block testosterone effects and might help prevent hair loss.

Heat transfer in hair is slower in groups of hair, increasing the risk of damage from high-temperature styling tools.

Cocaine impairs male sexual behavior and alters testosterone metabolism in the brain.

Telogen effluvium is a common, reversible hair loss condition treatable with patient education and sometimes Minoxidil.

Tgm2 helps stabilize dying cells and aids fibroblast attachment to the extracellular matrix.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

N-acetylcysteine may help treat trichotillomania.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

A parasite-derived molecule speeds up skin healing and affects immune cell behavior without increasing scarring.

TECAR therapy helps with pain relief, reduces inflammation, relaxes muscles, heals tissues, and is safe and effective for many conditions.

Telogen effluvium is a common, temporary hair loss condition often affecting young women.

Total skin electron therapy is an effective treatment for mycosis fungoides, balancing effectiveness and side effects.

MTS effectively improves hair density and thickness in menopausal women with hair loss.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

OnabotulinumtoxinA treatment improved hair-pulling disorder and hair regrowth in a woman with chronic migraines.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

Trichloroethylene causes skin inflammation in mice by increasing certain immune proteins.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

rTMS may help treat trichotillomania in some patients.

MPA increases cancer spread by boosting Eph A2 activity.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.